Abstract:Dendritic cells (DCs) play critical roles in cross-priming to induce the CTL response against infection; however, the molecular mechanisms for the regulation of DC cross-priming need to be investigated further, which may help to improve the potency of DC vaccines through engineering modifications. Our previous studies showed that β2 integrin CD11b could control TLR-triggered NK cell cytotoxicity and macrophage inflammatory responses. CD11b is also abundantly expressed in DCs, but it is unknown whether CD11b participates in the regulation of DC cross-priming for the CTL response. Also, because microRNAs (miRNAs) are important regulators of the immune response, it remains unclear whether miRNAs are regulated by CD11b in DCs. In this study, we showed that CD11b deficiency upregulated TLR9-triggered, but not TLR4-triggered, IL-12p70 production in DCs, subsequently promoting DC cross-priming of the CTL response. Further experiments showed that CD11b selectively promoted TLR9-triggered miR-146a upregulation in DCs by sustaining late-phase NF-κB activation. Additionally, Notch1, a known positive regulator of IL-12p70 production in DCs, was confirmed to be directly targeted by miR-146a. miR-146a upregulation and Notch1 repression were determined to be responsible for the reduced IL-12p70 production in TLR9-triggered wild-type DCs compared with that in CD11b-deficient DCs. Therefore, CD11b and downstream miR-146a may be new negative regulators for DC cross-priming by suppressing Notch1 expression and IL-12p70 production. Our data indicate a new mechanism for the regulation of DC cross-priming through integrins and miRNAs.

Cbl-b restrains priming of pathogenic Th17 cells via the inhibition of IL-6 production by macrophages

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

Bcl6 Modulates Innate Immunity by Controlling Macrophage Activity and Plays Critical Role in Experimental Autoimmune Encephalomyelitis

Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

Ablation of Cbl-b and C-Cbl in Dendritic Cells Causes Spontaneous Liver Cirrhosis Via Altering Multiple Properties of CD103+ Cdc1s

B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Negative Regulation of Cd40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B

NF-κB Downregulates Cbl-b Through Binding and Suppressing Cbl-b Promoter in T Cell Activation.

TH17 cells promote CNS inflammation by sensing danger signals via Mincle

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation

Cbl-b inhibited CD4+T cell activation by regulating the expression of miR-99a/miR-125b

E3 Ubiquitin Ligase Cbl-b Inhibits Type 2 Innate Lymphoid Cell Development by Targeting ST2 for Ubiquitination

Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis

Baff Promotes Th17 Cells And Aggravates Experimental Autoimmune Encephalomyelitis

Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses

E3 Ubiquitin Ligase Cbl-b Negatively Regulates C-type Lectin Receptor–mediated Antifungal Innate Immunity

IL-10 Engages Macrophages to Shift Th17 Cytokine Dependency and Pathogenicity During T Cell-Mediated Colitis (MUC8P.729)

Differential Regulation of the B Cell Receptor-mediated Signaling by the E3 Ubiquitin Ligase Cbl

Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation